Ken Griffin Seelos Therapeutics, Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$0.16 - $1.64 $4,512 - $46,248	28,200 Added 98.26%	56,900 $10,000
Q2 2023 Aug 14, 2023	BUY	$0.66 - $1.22 $6,732 - $12,444	10,200 Added 55.14%	28,700 $34,000
Q1 2023 May 15, 2023	SELL	$0.59 - $1.04 $34,515 - $60,840	-58,500 Reduced 75.97%	18,500 $12,000
Q4 2022 Feb 14, 2023	SELL	$0.66 - $1.34 $31,680 - $64,320	-48,000 Reduced 38.4%	77,000 $52,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $1.41 $57,850 - $125,490	89,000 Added 247.22%	125,000 $129,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.